# CYTALUX
> **NDA214907** · New Drug Application · Sponsor: ON TARGET LABS · Approved 2021-11-29
## Drug
- **FDA Application Number:** NDA214907
- **Application type:** New Drug Application
- **Brand name:** CYTALUX
- **Generic name:** PAFOLACIANINE INJECTION
- **Active ingredients:** PAFOLACIANINE SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ON TARGET LABS
- **Manufacturer:** On Target Laboratories, Inc.
- **First approval:** 2021-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214907)
---
*MORVS · CC0 1.0*